Evidence map›Paper›PMID 41457886›Full record

ArticleTurk psikiyatri dergisi = Turkish journal of psychiatry2025

Continued or Discontinued Antidepressant Treatment During Pregnancy? A Single Center Long Term Follow-up Study.

Zeynep Tirmikçioğlu

Abstract read
In one paragraph

Article in Turk psikiyatri dergisi = Turkish journal of psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Zeynep Tirmikçioğlu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to evaluate the long-term follow-up data and risks associated with untreated depression and antidepressant use in pregnancy.

methodPatients who received consultation at the Clinical Pharmacology and Toxicology Unit at the Izmir Ataturk Research and Training Hospital for concerns related to use of medication during pregnancy between 2016 and 2020 were included in the study. During the initial interviews with the patients, data were collected regarding maternal characteristics and drug exposures. In follow-up calls after delivery, detailed information about pregnancy and birth outcomes was gathered.

resultsAmong 2323 pregnant women who sought consultation due to drug use during pregnancy, 17% were receiving antidepressant treatment (398/2323). In follow-up calls, 290 women were reached. In women who had received no therapy during pregnancy (n=240), rates of gestational diabetes (p=0.02), pregnancy depression (p=0.01), postpartum depression (p<0.0001), and decreased breast milk (p=0.02) were significantly higher compared to women who continued treatment (n=50).

conclusionIn pregnant individuals with an ongoing antidepressant use, the benefits and risks of antidepressant continuation should be weighed carefully.

Indexed as

Antidepressive AgentsPregnancy ComplicationsAdultFemaleFollow-Up StudiesHumansPregnancyPregnancy OutcomeTurkeyYoung AdultAntidepressive AgentsAntidepressantdepressionnewborn pregnancy.

Identifiers

PMID41457886
PMCPMC12811945

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.